Allspring Global Investments Holdings LLC increased its stake in Humana Inc. (HUM), while Lecap Asset Management Ltd. acquired 14,827 shares and YHB Investment Advisors Inc. bought 2,301 shares. Several financial firms adjusted HUM's target price, with Truist, B of A Securities and Barclays all lowering their estimates. Humana reaffirmed its EPS guidance for 2025, however, the insurer's 2025 profit forecast fell below estimates due to an expected drop in membership.
An expanded Science-Based Target was validated by Humana and a new agreement has been reached with Thyme Care to extend value-based oncology care. Despite potential membership decline, Humana has secured a $5 billion credit agreement and loyalty seems strong as President James Rechtin bought 299% more shares.
The company's shares had some volatile moments, inclining after Medicare payment rates increased but later declining on industry concerns and CMS audit expansion. HUM reported strong Q1 earnings, particularly on the back of CenterWell Segment strength. While the company supports reforms to Medicare Advantage billing practices, it also achieved a big win for Medicare Advantage insurers leading to a surge in stock prices.
Humana also announced the declaration of a quarterly dividend to its stockholders, an aggregate $1.25 billion debt offering, and a 2025 initiative focusing on quality, affordable healthcare tailored to consumer needs.
Humana HUM News Analytics from Tue, 01 Oct 2024 07:00:00 GMT to Sat, 28 Jun 2025 10:50:55 GMT - Rating -1 - Innovation 5 - Information 8 - Rumor 6
